Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 18:56:30 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

Prostatype Genomics - Updated outlook

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Prostatype Genomics - Updated outlook

2023-06-08 08:40:00

The next US step is to sign a certified lab partner. In Europe, the company has secured partners in the Nordics and the Iberian Peninsula (Spain and Portugal). Prostatype closed a new share issue amounting to SEK 24m before costs in May. We are updating our base case reflecting the recent right issue and an updated outlook. Our updated view is a base case valuation of SEK 0.90 and a Bull Case of SEK 1.80 and a Bear Case of SEK 0.10. Our Base case includes an additional fund raising within twelve months.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/